125 related articles for article (PubMed ID: 30760861)
1. Accumulation of fructose 1,6-bisphosphate protects clear cell renal cell carcinoma from oxidative stress.
Wang J; Wu Q; Qiu J
Lab Invest; 2019 Jun; 99(6):898-908. PubMed ID: 30760861
[TBL] [Abstract][Full Text] [Related]
2. Aldolase B attenuates clear cell renal cell carcinoma progression by inhibiting CtBP2.
Tan M; Pan Q; Wu Q; Li J; Wang J
Front Med; 2023 Jun; 17(3):503-517. PubMed ID: 36790589
[TBL] [Abstract][Full Text] [Related]
3. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
[TBL] [Abstract][Full Text] [Related]
4. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma.
Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X
Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827
[TBL] [Abstract][Full Text] [Related]
5. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
[TBL] [Abstract][Full Text] [Related]
6. HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells.
Teng R; Liu Z; Tang H; Zhang W; Chen Y; Xu R; Chen L; Song J; Liu X; Deng H
Redox Biol; 2019 Jun; 24():101218. PubMed ID: 31112866
[TBL] [Abstract][Full Text] [Related]
7. Fructose 1,6-Bisphosphatase 1 Expression Reduces
Chen R; Zhou X; Huang G; Liu J
Contrast Media Mol Imaging; 2019; 2019():9463926. PubMed ID: 30723389
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
9. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
[TBL] [Abstract][Full Text] [Related]
10. Phosphoinositide-dependent kinase 1-associated glycolysis is regulated by miR-409-3p in clear cell renal cell carcinoma.
Wang Y; He Y; Bai H; Dang Y; Gao J; Lv P
J Cell Biochem; 2019 Jan; 120(1):126-134. PubMed ID: 30218446
[TBL] [Abstract][Full Text] [Related]
11. RASSF6 promotes p21(Cip1/Waf1)-dependent cell cycle arrest and apoptosis through activation of the JNK/SAPK pathway in clear cell renal cell carcinoma.
Liang YY; Zheng LS; Wu YZ; Peng LX; Cao Y; Cao X; Xie P; Huang BJ; Qian CN
Cell Cycle; 2014; 13(9):1440-9. PubMed ID: 24626183
[TBL] [Abstract][Full Text] [Related]
12. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
[TBL] [Abstract][Full Text] [Related]
13. High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival.
Rabjerg M; Oliván-Viguera A; Hansen LK; Jensen L; Sevelsted-Møller L; Walter S; Jensen BL; Marcussen N; Köhler R
PLoS One; 2015; 10(4):e0122992. PubMed ID: 25848765
[TBL] [Abstract][Full Text] [Related]
14. Structural insights into the substrate binding and stereoselectivity of giardia fructose-1,6-bisphosphate aldolase.
Galkin A; Li Z; Li L; Kulakova L; Pal LR; Dunaway-Mariano D; Herzberg O
Biochemistry; 2009 Apr; 48(14):3186-96. PubMed ID: 19236002
[TBL] [Abstract][Full Text] [Related]
15. Fructose 1,6-bisphosphate aldolase/phosphatase may be an ancestral gluconeogenic enzyme.
Say RF; Fuchs G
Nature; 2010 Apr; 464(7291):1077-81. PubMed ID: 20348906
[TBL] [Abstract][Full Text] [Related]
16. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
17. L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells.
Doberstein K; Wieland A; Lee SB; Blaheta RA; Wedel S; Moch H; Schraml P; Pfeilschifter J; Kristiansen G; Gutwein P
Carcinogenesis; 2011 Mar; 32(3):262-70. PubMed ID: 21097529
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma.
Hu W; Su Y; Fei X; Wang X; Zhang G; Su C; Du T; Yang T; Wang G; Tang Z; Zhang J
Oncol Rep; 2020 Jun; 43(6):1964-1974. PubMed ID: 32236633
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
[TBL] [Abstract][Full Text] [Related]
20. An essential role for GLUT5-mediated fructose utilization in exacerbating the malignancy of clear cell renal cell carcinoma.
Jin X; Liang Y; Liu D; Luo Q; Cai L; Wu J; Jia L; Chen WL
Cell Biol Toxicol; 2019 Oct; 35(5):471-483. PubMed ID: 31102011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
